Skip to content
Home/Companies/MedTech/ARK Diagnostics
AD

ARK Diagnostics

MedTech·US·Active·1yr hold

ARK Diagnostics is a diagnostics company, headquartered in United States.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns ARK Diagnostics?

ARK Diagnostics is currently owned by ARCHIMED through MED Platform II (2022 vintage), since 2025.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED Platform II · 2022 · Buyout

Key facts

HQUnited States
SectorDiagnostics

More from MED Platform II

Other portfolio companies in the same fund.

Instem
Active
HealthTechUS· 2023
Symbio
Active
PharmaUS· 2023
WiQo
Active
HealthTechItaly· 2023
Corealis
Active
PharmaCanada· 2022
Natus
Active
MedTechUS· 2022

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings